However, Xu et al. found that although methylation of the BRCA1 promoter was more prevalent in cancers with tumors size greater than 2 cm, hypermethylation of BRCA1 from breast cancers with BRCA1 mutations had no overall correlation with ER, PR or grade [16]. The gene discussed is BRCA1; the disease is breast cancer.